Kaitlin Kestenberg
Fortuna: 1 M $ al 31/05/2026
Fortuna: 1 M $ al 31/05/2026
Kaitlin M.
Kestenberg is currently Chief Operating Officer & Senior VP-Compliance at ADMA Biologics, Inc. since 2024.
Education includes graduate studies at Seton Hall University and undergraduate studies at State University of New York at Albany.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ADMA BIOLOGICS, INC. 0,06 % | 31/03/2026 | 133.641 ( 0,06 % ) | 1 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ADMA BIOLOGICS, INC. | Oficial de Cumplimiento | 01/01/2018 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
ADMA Biologics, Inc.
ADMA Biologics, Inc. BiotechnologyHealth Technology Develops, manufactures and markets specialty biologics | Health Technology |
Seton Hall University
Seton Hall University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
State University of New York at Albany
State University of New York at Albany Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.